APLS Jan 2026 30.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:25PM EDT. Market open.
| Previous close | 2.2500 |
| Open | 2.5500 |
| Bid | 2.7000 |
| Ask | 4.9000 |
| Strike | 30.00 |
| Expiry date | 2026-01-16 |
| Day's range | 2.2500 - 2.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 72 |
Insider MonkeyApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54. Apellis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Simply Wall St.Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apellis Pharmaceuticals ( NASDAQ:APLS ) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284...
- GuruFocus.com
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.
© 2024 Yahoo. All rights reserved.